Received Sep 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
the patient has received her MMR and varicella vaccines in the past. The patient was then inadvertently given PROQUAD (unknown date) in order to provide a booster for the series.; This spontaneous report was received from a physician assistant (reported as medical assistant and refers to a 27-year-old female patient. The patient's concurrent conditions included drug allergy (minocycline). Historical drugs included minocycline. The patient concomitant therapies, previous drugs reactions and allergies were not reported. On an unknown date (reported as in the past), the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (reported as MMR vaccine) (manufacturer unknown, reported as unknown brand name) and with a dose of varicella virus vaccine live (oka-merck) (VARIVAX) (reported as varicella vaccine) (manufacturer unknown reported as unknown brand name) both administered as prophylaxis (strengths, Lot numbers, expirations dates, dose numbers, exact dose quantity volumes, routes and anatomical locations of administration and vaccination scheme frequencies were not provided); that were reconstituted with sterile diluent (Lot No., expiration date, route and indication were not reported). On an unknown date, the patient experienced antibody test abnormal, abortion spontaneous and exposure during pregnancy (captured in PV smart 2331386). On an unknown date, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live lyophilisate and solvent for solution for injection (PROQUAD) administered as prophylaxis (Lot No., expiration date, strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided; that were reconstituted with sterile diluent (Lot No., expiration date, route and indication were not reported); in order to provide a booster for the series (product use issue).
Drug allergy
Sterile diluent